Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Huber

Showing results (191-200 of 224) with videos related to

Pageof 23
Sort By:
Frontiers in Immunology|January 25, 2024
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver diseaseLorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Science Advances|August 14, 2021
Efferocytosis fuels malignant pleural effusion through TIMP1Lilan Zhao, Anastasios D Giannou, Yang Xu, et al.
Nature Communications|April 20, 2026
Indirect inhibition of the NLRP3-interleukin-1β axis contributes to the efficacy of JAK1 inhibitors in experimental colitis and human ulcerative colitisBeibei Liu, Marianne R Spalinger, Annalisa Invernizzi, et al.
Hepatology (Baltimore, Md.)|October 22, 2020
Monocytes as Potential Mediators of Pathogen-Induced T-Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC)Lilly Kristin Kunzmann, Tanja Schoknecht, Tobias Poch, et al.
Annals of Hepatology|October 13, 2025
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumabLorenz Kocheise, Jan Kempski, Yunhe Tang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 8, 2024
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapyJoao Gorgulho, Sven H Loosen, Ramsha Masood, et al.
Nature Immunology|August 14, 2023
Short-term dietary changes can result in mucosal and systemic immune depressionFrancesco Siracusa, Nicola Schaltenberg, Yogesh Kumar, et al.
JCI Insight|January 10, 2023
Multicytokine-producing CD4+ T cells characterize the livers of patients with NASHAnna Woestemeier, Pasquale Scognamiglio, Yu Zhao, et al.
Science (New York, N.Y.)|April 4, 2024
Apoptotic cell identity induces distinct functional responses to IL-4 in efferocytic macrophagesImke Liebold, Amirah Al Jawazneh, Christian Casar, et al.
Nature|May 13, 2025
Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancerJoseph Tintelnot, Yang Xu, Till R Lesker, et al.
Pageof 23

Showing results (191-200 of 224) with videos related to

Sort By:
Pageof 23
Frontiers in Immunology|January 25, 2024
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver diseaseLorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Science Advances|August 14, 2021
Efferocytosis fuels malignant pleural effusion through TIMP1Lilan Zhao, Anastasios D Giannou, Yang Xu, et al.
Nature Communications|April 20, 2026
Indirect inhibition of the NLRP3-interleukin-1β axis contributes to the efficacy of JAK1 inhibitors in experimental colitis and human ulcerative colitisBeibei Liu, Marianne R Spalinger, Annalisa Invernizzi, et al.
Hepatology (Baltimore, Md.)|October 22, 2020
Monocytes as Potential Mediators of Pathogen-Induced T-Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC)Lilly Kristin Kunzmann, Tanja Schoknecht, Tobias Poch, et al.
Annals of Hepatology|October 13, 2025
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumabLorenz Kocheise, Jan Kempski, Yunhe Tang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 8, 2024
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapyJoao Gorgulho, Sven H Loosen, Ramsha Masood, et al.
Nature Immunology|August 14, 2023
Short-term dietary changes can result in mucosal and systemic immune depressionFrancesco Siracusa, Nicola Schaltenberg, Yogesh Kumar, et al.
JCI Insight|January 10, 2023
Multicytokine-producing CD4+ T cells characterize the livers of patients with NASHAnna Woestemeier, Pasquale Scognamiglio, Yu Zhao, et al.
Science (New York, N.Y.)|April 4, 2024
Apoptotic cell identity induces distinct functional responses to IL-4 in efferocytic macrophagesImke Liebold, Amirah Al Jawazneh, Christian Casar, et al.
Nature|May 13, 2025
Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancerJoseph Tintelnot, Yang Xu, Till R Lesker, et al.
Pageof 23